Corrigendum: Severe toxic rhabdomyolysis under combined palbociclib and simvastatin treatment: A case report

Front Oncol. 2023 Feb 7:13:1149399. doi: 10.3389/fonc.2023.1149399. eCollection 2023.

¹ Department of Medical Oncology, Institut Claudius Regaud - Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France.
² Department of Clinical Pharmacy, Institut Claudius Regaud - Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France.
³ Department of Internal Medicine and Clinical Immunology, Centre Hospitalier Universitaire Toulouse, Toulouse, France.
⁴ Department of Nephrology, Centre Hospitalier Universitaire Toulouse, Toulouse, France.
⁵ Department of Anatomo-pathology, Institut Universitaire du Cancer de Toulouse -Oncopole, Toulouse, France.
⁶ Department of Neurology, Centre Hospitalier Universitai Toulouse -Purpan, Toulouse, France.

Abstract

[This corrects the article DOI: 10.3389/fonc.2022.1026434.].

Keywords: interaction; myositis; palbociclib; plasmatic exchange; rhabdomyolysis; simvastatin.